Lynn Kirkpatrick

2022

In 2022, Lynn Kirkpatrick earned a total compensation of $622.6K as Chief Executive Officer at Ensysce Biosciences, a 116% increase compared to previous year.

Compensation breakdown

Option Awards$214,914
Salary$392,500
Other$15,195
Total$622,609

Kirkpatrick received $392.5K in salary, accounting for 63% of the total pay in 2022.

Kirkpatrick also received $214.9K in option awards and $15.2K in other compensation.

Rankings

In 2022, Lynn Kirkpatrick's compensation ranked 3,948th out of 5,625 executives tracked by ExecPay. In other words, Kirkpatrick earned more than 29.8% of executives.

ClassificationRankingPercentile
All
3,948
out of 5,625
30th
Division
Manufacturing
2,228
out of 3,053
27th
Major group
Chemicals And Allied Products
1,073
out of 1,380
22nd
Industry group
Drugs
1,006
out of 1,281
22nd
Industry
Pharmaceutical Preparations
732
out of 927
21st
Source: SEC filing on July 13, 2023.

Kirkpatrick's colleagues

We found two more compensation records of executives who worked with Lynn Kirkpatrick at Ensysce Biosciences in 2022.

2022

David Humphrey

Ensysce Biosciences

Chief Financial Officer

2022

Geoff Birkett

Ensysce Biosciences

Chief Commercial Officer

News

You may also like